Nutrix, a Swiss medical technology startup, is starting a partnership with Farmacias Ahumadato SpA, which owns more than 350 pharmacies in Chile. With the signed agreement, the startup will be able to start selling gSense and the 360° ecosystem for people with type 2 diabetes in this market.
Nutrix plans to launch its operations in Chile, in March 2022. In the next 12 months, it wants to hire as many as 53 employees, mainly doctors, nutritionists and administrative staff.
In the initial phase, the company will aim to have a user base of 14,000. The Nutrix solution is designed to help people change the habits necessary to control obesity or manage a pre-diabetic condition.